Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case

by Sergio I. Prada, Victoria E. Soto, Tatiana S. Andia, Claudia P. Vaca, Álvaro A. Morales, Sergio R. Márquez, Alejandro Gaviria
Published 2018-03-01